Dr Najla Nouri Falaki, MD | |
2015 Mayflower Dr, Silver Spring, MD 20905-5564 | |
(301) 384-0019 | |
Not Available |
Full Name | Dr Najla Nouri Falaki |
---|---|
Gender | Female |
Speciality | Pediatrics |
Location | 2015 Mayflower Dr, Silver Spring, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023110632 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | D44083 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Najla Nouri Falaki, MD 2015 Mayflower Dr, Silver Spring, MD 20905-5564 Ph: (301) 384-0019 | Dr Najla Nouri Falaki, MD 2015 Mayflower Dr, Silver Spring, MD 20905-5564 Ph: (301) 384-0019 |
News Archive
An international team of scientists, led by University of California San Diego School of Medicine researchers, has created a human stem cell-based model of a rare, but devastating, inherited neurological autoimmune condition called Aicardi-Goutieres Syndrome (AGS).
Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences, submitted their findings to ACS Nano, a monthly peer-reviewed scientific journal, on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SARS-CoV-2 Spike proteins and human cells.
Wright Medical Group, Inc., a global orthopaedic medical device company, today announced that it has launched a new subsidiary, Wright Medical Australia Pty, LTD. The new entity will directly manage all of the Company's extremity and biologics distribution for customers in Australia and New Zealand.
Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.
While PCR testing has been used widely for COVID-19 diagnosis, it only provides information on who is currently infected. Antibody testing can tell who has been previously exposed to SARS-CoV-2, the virus that causes COVID-19, a metric that is essential for tracking spread across a population.
› Verified 4 days ago
Dr. Erica Rupar, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10301 Georgia Ave, #106, Silver Spring, MD 20902 Phone: 301-681-6000 | |
Dr. Robin Madden, M.D., PH.D, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10313 Georgia Ave, Suite 303, Silver Spring, MD 20902 Phone: 301-681-7020 Fax: 301-681-0147 | |
Dr. Laila A. Mahmood, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 15613 Holly Grove Rd, Silver Spring, MD 20905 Phone: 301-384-3579 | |
Dr. Cyd Patrice Campbell, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 102 Southwood Ave, Silver Spring, MD 20901 Phone: 301-213-3679 | |
Dr. Lisa S Thompson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 301-905-3600 | |
Liza S Burns, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 10301 Georgia Ave, Suite 106, Silver Spring, MD 20902 Phone: 301-681-6000 Fax: 301-681-3153 |